MyFinsight
Home
Blog
About
Marketable securities
$270,374K
(57.63%↑ Y/Y)
Cash and cash
equivalents
$48,466K
(13.80%↑ Y/Y)
Prepaid expenses and
other current assets
$4,011K
(-23.77%↓ Y/Y)
Total current assets
$322,851K
(47.17%↑ Y/Y)
Restricted cash
$1,092K
(-9.38%↓ Y/Y)
Other assets
$9K
(-25.00%↓ Y/Y)
Total assets
$323,952K
(41.56%↑ Y/Y)
Total liabilities and
stockholders equity
$323,952K
(41.56%↑ Y/Y)
Total stockholders
equity
$310,697K
(44.93%↑ Y/Y)
Total liabilities
$13,255K
(-8.33%↓ Y/Y)
Accumulated deficit
-$639,348K
(-15.33%↓ Y/Y)
Accumulated other
comprehensive (loss) gain
-$567K
(-791.46%↓ Y/Y)
Additional paid-in capital
$950,536K
(23.67%↑ Y/Y)
Total current
liabilities
$10,298K
(14.61%↑ Y/Y)
Operating lease
liability, excluding...
$2,760K
(-47.71%↓ Y/Y)
Other liabilities,
excluding current portion
$197K
(0.00%↑ Y/Y)
Common stock, 0.001 par
value 200,000,000...
$76K
(40.74%↑ Y/Y)
Accrued expenses and
other current...
$4,355K
(-11.86%↓ Y/Y)
Accounts payable
$3,425K
(95.60%↑ Y/Y)
Operating lease
liability, current
$2,518K
(9.81%↑ Y/Y)
Back
Back
Balance Sheet
Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. (FULC)
source: myfinsight.com